A rapid method for determining low concentrations of 210Pb in drinking water using MnO2 fibers.

A rapid method for determining low activity concentrations of 210Pb in drinking water was developed and tested. The method consists of a few stages for sample preparation that involve passing 12 L of water through a column with acrylic fibers implanted with MnO2 (used to adsorb 210Pb). The MnO2 fibers are oven-dried, compressed and measured by a broad-energy germanium detector used to quantify 210Pb via its characteristic 46.5 keV γ-ray. The time taken for sample preparation is approximately 4 h and recovery factors for lead in tap water of 87 ± 3% were achieved. After a measurement duration of 4 h, the minimum detectable activity concentration reaches 0.02 Bq/L for 210Pb, being well below the respective limit for drinking water in Israel (0.2 Bq/L) as well as the value recommended by the World Health Organization (0.1 Bq/L). Furthermore, a measurement duration of 48 h provides a minimum detectable activity concentration of ∼0.006 Bq/L, which is similar in magnitude to other, well-established methods that rely on lengthy and rather complex procedures. Thus, the combination of MnO2 fibers and gamma-ray spectrometry may be attractive for routine use by analytical laboratories that monitor radioactivity in drinking water.

A METHOD TO IDENTIFY AND LOCALIZE A SINGLE HOT PARTICLE IN THE LUNGS USING AN ARRAY OF HIGH-PURITY GERMANIUM DETECTORS FOR IMPROVED ESTIMATE OF THE DEPOSITED ACTIVITY.

A new method has been developed to identify and localize a single hot particle in the lungs using an array of four high-purity germanium detectors. The method is based upon calculating a set of three count rate ratios (generated by each individual detector in the array) that are evaluated in sequence to designate whether the measured deposition can be associated with a hot particle rather than the default assumption of a uniform activity distribution. Identification and localization of the hot particle are determined from a single in vivo measurement in which detectors are positioned above and below the thorax. The method was tested using an anthropomorphic thorax phantom in which point sources of 241Am, 137Cs and 60Co were individually inserted in the lungs at 15 different locations and were measured using a scanning bed whole-body counter. Depending upon source location and photon energy, a bias of -35% up to +76% could be introduced by falsely assuming a uniform activity distribution in the lungs. This bias would directly translate to an erroneous dose estimate to the lungs. It was demonstrated that by using the appropriate detector efficiencies for the single hot particle, the bias associated with the activity determination is reduced to <10% and ~2% in average.